EUVIMEDOpdag EUVIMED
Crossref

A 3‐step method for preparing cryopreserved samples of apheresis products for post‐thaw analysis yields a higher percentage of viable cells

Dustin J Strasburg, Rosalie M Sterner iD, Sildane Va, Eapen K Jacob, Margaret A DiGuardo

Transfusion · 2024

DOI: 10.1111/trf.17822 ↗

At a glance

Journal article in Transfusion, 2024. Written by Dustin J Strasburg and 4 co-authors. Institution: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. Major MEDLINE topics: Cryopreservation, Cell Survival, Flow Cytometry, Blood Component Removal. Cited 1 times so far (Crossref); 9 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Standard flow cytometry protocols for CD34+ cell enumeration designed for fresh samples are not appropriate for cryopreserved products. Special protocols have been developed to remove the cryoprotectant by quickly washing a freshly thawed sample. Exposing cells to a large volume of hypotonic solution and subsequent washing process was hypothesized to cause lab‐induced cell death. Moreover, standard gating strategies must be altered to avoid reporting falsely high viabilities. Study Design and Methods We developed a novel method whereby thawed samples were diluted step‐wise to 1:2 by 3 additions of 1/3 sample volume using 1% Human Albumin in Dextran 40 (10% Low Molecular Weight Dextran in 0.9% NaCl) separated by 5 min between each addition. An additional 1:10 dilution was required to obtain a desired cell concentration for flow cytometry testing resulting in a 1:20 dilution.

Results

Twenty samples were tested simultaneously in a method comparison; the new method demonstrated significant increases in mean cell viabilities for white blood cells, hematopoietic progenitor cells, and T cells as well as reduced standard deviations for each parameter.

Discussion

Slow, step‐wise dilutions of freshly thawed samples of cryopreserved apheresis products to 1:20 yielded higher and more precise viability measurements compared to quickly washing samples to remove DMSO.

Subjects

MeSH terms (MEDLINE)

CryopreservationCell SurvivalFlow CytometryBlood Component RemovalHumansHematopoietic Stem CellsBlood PreservationCryoprotective AgentsAntigens, CD34

Author keywords

CD34HPCcryopreservationpost‐thawviability

Substances

Cryoprotective AgentsAntigens, CD34

Authors and institutions

  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

ORCID profiles: Rosalie M Sterner

Cite

APA

Strasburg, D. J., Sterner, R. M., Va, S., Jacob, E. K., & DiGuardo, M. A. (2024). A 3‐step method for preparing cryopreserved samples of apheresis products for post‐thaw analysis yields a higher percentage of viable cells. Transfusion. https://doi.org/10.1111/trf.17822

Vancouver

Strasburg DJ, Sterner RM, Va S, Jacob EK, DiGuardo MA. A 3‐step method for preparing cryopreserved samples of apheresis products for post‐thaw analysis yields a higher percentage of viable cells. Transfusion. 2024. doi:10.1111/trf.17822

BibTeX
@article{Strasburg2024,
  author = {Strasburg, Dustin J and Sterner, Rosalie M and Va, Sildane and Jacob, Eapen K and DiGuardo, Margaret A},
  title = {A 3‐step method for preparing cryopreserved samples of apheresis products for post‐thaw analysis yields a higher percentage of viable cells},
  journal = {Transfusion},
  year = {2024},
  doi = {10.1111/trf.17822}
}
Start for free →